An announcement is made by Takeda Oncology Company and Takeda Pharmaceutical Company Limited conditional marketing authorization for ADCETRIS for two indications: (1) the treatment of adult patients with relapsed or refractory CD30 positive Hodgkin lymphoma (HL) following autologous stem cell transplant (ASCT) or following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option, and (2) for the treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL).
What does MA stand for?
MA stands for Marketing Authorization
This definition appears very frequently and is found in the following Acronym Finder categories:
- Business, finance, etc.
See other definitions of MA
We have 141 other meanings of MA in our Acronym Attic
- Manual Assist (nursing)
- Manufacturing Approval
- Map Analysis
- Maranhao (Brazil)
- Maranhão (Brazilian state)
- Margin Agreement
- Marijuana Anonymous
- Marin Academy (California)
- Maritime Administration
- Market America (independent entrepenurial corporation founded by James H Ridinger)
Samples in periodicals archive:
Lancet Oncology Editor Comments on EU Conditional Marketing Authorization SEATTLE, May 31, 2012 /PRNewswire/ -- Cell Therapeutics, Inc.
NASDAQ: TARO) has reported that Taro Pharmaceuticals (UK) Limited (Taro UK), its affiliate in the United Kingdom, has been granted a marketing authorization for Etopan XL Tablets 600 mg, Etodolac (Etopan XL) by the Medicines and Healthcare Products Regulatory Agency, the UK equivalent of the U.
First Application for Marketing Authorization in European Union MADISON, N.
Taro," NASDAQ: TARO) reported today that Taro Pharmaceuticals (UK) Limited ("Taro UK"), its affiliate in the United Kingdom, has been granted a marketing authorization for Etopan XL Tablets 600 mg, Etodolac ("Etopan XL") by the Medicines and Healthcare Products Regulatory Agency, the UK equivalent of the U.
PhotoCure ASA, Oslo, Norway, has announced that the Australian Drug Evaluation Committee (ADEC) has recommended extension of the current marketing authorization for Metvix to include the treatment of basal cell carcinoma (BCC, the most common type of skin cancer).
Both analyses bode well for the global regulatory climate for our lead drug candidate Dyloject, whose marketing authorization application for Europe is now under review and that is now in Phase III trails in the US.
PARIS -- BioAlliance Pharma SA (Paris:BIO), an emerging specialty pharmaceutical company focused on the development of innovative therapeutics targeting drug resistance in cancer, HIV, and severe and opportunistic infections, announced today that the Company has received marketing authorization for Loramyc[R] (miconazole Lauriad) from France's regulatory body, AFSSAPS (Agence FranE*aise de SE[umlaut]curitE[umlaut] Sanitaire des Produits de SantE[umlaut]).